ACTON, Mass., Sept. 26, 2017 /PRNewswire/ -- Psychemedics
Corporation (NASDAQ:PMD), hair testing pioneer and global leader
for over thirty years, announced the launch of its FDA-Cleared
Benzodiazepines hair test. The test detects numerous
Benzodiazepines, including Xanax®, Valium®, and Ativan®, and is
available as a stand-alone test or as an option on Psychemedics'
standard drug panels.
The abuse of prescription Benzodiazepines has grown at an
alarming rate in the United
States, contributing to thousands of emergency room visits
and overdose deaths each year. It is important to note that
Benzodiazepines can prove deadly when combined with other
depressants, including alcohol. This significantly increases
the danger of Benzodiazepine abuse.
Psychemedics' non-invasive testing procedure uses a small sample
of hair that is easily collected and shipped to Psychemedics'
College of American Pathologists (CAP) and ISO-IEC 17025:2005
certified laboratory. Unlike urinalysis or oral fluid testing
which typically detects drug use for only the previous one to three
days, Psychemedics hair analysis can detect use over the previous
few months.
Advancing The Science of Hair Testing
Psychemedics is the first hair testing laboratory to have its
test for Benzodiazepines cleared by the FDA. Continued advancement
in the science of hair testing is critical to Psychemedics, and the
development of this new test provides the market with a unique and
reliable test that identifies and measures the use of
Benzodiazepines over a period of time. The Benzodiazepines
test follows Psychemedics' recent announcement of the addition of
the first hair test for synthetic cannabinoids for the
workplace.
Raymond C. Kubacki, Chairman and
CEO stated: "Sadly, the abuse of prescription drugs is now rampant
in the United States. We are extremely concerned about this
problem, and are doing everything in our power to address it.
Today, we are pleased to establish another first: the first hair
testing laboratory to have its Benzodiazepines test cleared by the
FDA. As the scientific leader in drug testing, we at
Psychemedics continue to advance the science and use our top flight
scientific team and R&D resources to develop new tests that
will deter people from abusing prescription drugs."
About Psychemedics Corporation
Psychemedics Corporation is the world's largest provider of hair
testing for drugs of abuse and has been successfully operating for
over 30 years. Thousands of corporations rely on the patented
Psychemedics drug testing services. Psychemedics' clients include
over 10% of the Fortune 500, some of the largest police departments
in America, Federal Reserve Banks, and schools.
For more information, visit the Psychemedics Corporation website
at www.psychemedics.com.
Contact:
Raymond C. Kubacki
Chairman & CEO
(978) 206-8220
Cautionary Statement for purposes of the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995:
From time to time, information provided by Psychemedics may contain
forward-looking information that involves risks and uncertainties.
In particular, statements contained in this release that are not
historical facts (including but not limited to statements
concerning technological changes, technological advantages,
regulatory matters, implementation of new testing procedures and
processes, research and development, future business and marketing
strategies) may be "forward looking" statements. Actual results may
differ from those stated in any forward-looking statements. Factors
that may cause such differences include but are not limited to
risks associated with implementation of new testing procedures and
methodologies including training, personnel changes, changes in
supplier relationships, customer contract provisions and customer
relationships, government regulation, including but not limited to
FDA regulations, competition and general economic conditions and
other factors disclosed in the Company's filings with the
Securities and Exchange Commission.
View original content with
multimedia:http://www.prnewswire.com/news-releases/psychemedics-announces-addition-of-fda-cleared-benzodiazepines-hair-test-300526148.html
SOURCE Psychemedics Corporation